kind,identifier,name,source,license,url,description,chromosome
Pharmacologic Class,N0000007632,Thyroxine,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000007632,,
Pharmacologic Class,N0000011272,Thiazolidinediones,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000011272,,
Pharmacologic Class,N0000178477,Decreased Blood Pressure,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000178477,,
Pharmacologic Class,N0000010288,Osmotic Activity,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000010288,,
Pharmacologic Class,N0000190114,Cytochrome P450 3A Inhibitors,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000190114,,
Pharmacologic Class,N0000175799,Dopamine D2 Antagonists,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000175799,,
Pharmacologic Class,N0000000114,Dopamine Uptake Inhibitors,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000000114,,
Pharmacologic Class,N0000175732,Neuromuscular Nondepolarizing Blockade,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000175732,,
Pharmacologic Class,N0000175729,Central Nervous System Stimulation,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000175729,,
Pharmacologic Class,N0000008779,Decreased Parasympathetic Acetylcholine Activity,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000008779,,
Pharmacologic Class,N0000007618,Ergolines,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000007618,,
Pharmacologic Class,N0000175654,Gonadotropin Releasing Hormone Receptor Agonists,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000175654,,
Pharmacologic Class,N0000167094,Benzothiazoles,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000167094,,
Pharmacologic Class,N0000020024,Sclerosing Activity,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000020024,,
Pharmacologic Class,N0000175379,Arteriolar Vasodilation,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000175379,,
Pharmacologic Class,N0000175764,Serotonin 1d Receptor Agonists,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000175764,,
Pharmacologic Class,N0000175914,Increased Coagulation Factor VIII Activity,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000175914,,
Pharmacologic Class,N0000007151,Folic Acid,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000007151,,
Pharmacologic Class,N0000008053,Sulfones,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000008053,,
Pharmacologic Class,N0000191267,Cytochrome P450 2D6 Inducers,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000191267,,
Pharmacologic Class,N0000175089,Calcium Chelating Activity,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000175089,,
Pharmacologic Class,N0000008486,Decreased Central Nervous System Disorganized Electrical Activity,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000008486,,
Pharmacologic Class,N0000008479,Decreased Cell Wall Synthesis & Repair,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000008479,,
Pharmacologic Class,N0000009947,Nucleoside Reverse Transcriptase Inhibitors,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000009947,,
Pharmacologic Class,N0000009176,Increased Cellular Death,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000009176,,
Pharmacologic Class,N0000011281,Penicillins,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000011281,,
Pharmacologic Class,N0000000070,Angiotensin 2 Receptor Antagonists,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000000070,,
Pharmacologic Class,N0000175087,Urease Inhibitors,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000175087,,
Pharmacologic Class,N0000185007,Adrenergic beta3-Agonists,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000185007,,
Pharmacologic Class,N0000000083,Leukotriene Receptor Antagonists,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000000083,,
Pharmacologic Class,N0000191264,P-Glycoprotein Inducers,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000191264,,
Pharmacologic Class,N0000011414,Ketolides,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000011414,,
Pharmacologic Class,N0000007647,Nitrates,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000007647,,
Pharmacologic Class,N0000187062,Cytochrome P450 2C8 Inhibitors,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000187062,,
Pharmacologic Class,N0000006277,Vitamin D,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000006277,,
Pharmacologic Class,N0000191272,UGT1A1 Inhibitors,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000191272,,
Pharmacologic Class,N0000175915,Increased Coagulation Factor VIII Concentration,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000175915,,
Pharmacologic Class,N0000175960,Increased Glutathione Concentration,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000175960,,
Pharmacologic Class,N0000008953,Decreased Striated Muscle Contraction,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000008953,,
Pharmacologic Class,N0000010262,Neurokinin 1 Antagonists,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000010262,,
Pharmacologic Class,N0000009282,Increased Dopamine Activity,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000009282,,
Pharmacologic Class,N0000182138,Cytochrome P450 1A2 Inhibitors,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000182138,,
Pharmacologic Class,N0000175359,Increased Diuresis,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000175359,,
Pharmacologic Class,N0000187063,Cytochrome P450 2C8 Inducers,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000187063,,
Pharmacologic Class,N0000175512,Methylated Sulfonamides,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000175512,,
Pharmacologic Class,N0000190111,Organic Anion Transporter 3 Inhibitors,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000190111,,
Pharmacologic Class,N0000006999,Urea,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000006999,,
Pharmacologic Class,N0000191265,Organic Cation Transporter 1 Inhibitors,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000191265,,
Pharmacologic Class,N0000000160,Cyclooxygenase Inhibitors,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000000160,,
Pharmacologic Class,N0000000151,Histamine H2 Receptor Antagonists,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000000151,,
Pharmacologic Class,N0000007544,Phenothiazines,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000007544,,
Pharmacologic Class,N0000009948,Non-Nucleoside Reverse Transcriptase Inhibitors,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000009948,,
Pharmacologic Class,N0000007715,Catecholamines,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000007715,,
Pharmacologic Class,N0000005760,Aminosalicylic Acids,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000005760,,
Pharmacologic Class,N0000175516,RNA Synthetase Inhibitors,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000175516,,
Pharmacologic Class,N0000171207,Porphyrinogens,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000171207,,
Pharmacologic Class,N0000008859,Decreased Renal K+ Excretion,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000008859,,
Pharmacologic Class,N0000009371,Increased Large Intestinal Motility,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000009371,,
Pharmacologic Class,N0000009963,Thrombin Inhibitors,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000009963,,
Pharmacologic Class,N0000000116,GABA B Agonists,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000000116,,
Pharmacologic Class,N0000008832,Decreased Platelet Aggregation,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000008832,,
Pharmacologic Class,N0000007659,Nitrogen Mustard Compounds,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000007659,,
Pharmacologic Class,N0000000115,Progestational Hormone Receptor Antagonists,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000000115,,
Pharmacologic Class,N0000008836,Decreased Prostaglandin Production,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000008836,,
Pharmacologic Class,N0000184306,Cell-mediated Immunity,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000184306,,
Pharmacologic Class,N0000010259,Ultrasound Contrast Activity,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000010259,,
Pharmacologic Class,N0000008683,Decreased Leukotriene Production,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000008683,,
Pharmacologic Class,N0000175830,Inhibit Ovum Fertilization,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000175830,,
Pharmacologic Class,N0000175080,Aromatase Inhibitors,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000175080,,
Pharmacologic Class,N0000187064,Cytochrome P450 2B6 Inducers,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000187064,,
Pharmacologic Class,N0000175967,Thrombopoietin Receptor Interactions,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000175967,,
Pharmacologic Class,N0000000235,Carbonic Anhydrase Inhibitors,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000000235,,
Pharmacologic Class,N0000006269,Vitamin A,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000006269,,
Pharmacologic Class,N0000007909,Psoralens,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000007909,,
Pharmacologic Class,N0000175921,Adrenal Steroid Synthesis Inhibitors,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000175921,,
Pharmacologic Class,N0000007529,Macrolides,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000007529,,
Pharmacologic Class,N0000006996,Cholecalciferol,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000006996,,
Pharmacologic Class,N0000009911,Venous Vasodilation,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000009911,,
Pharmacologic Class,N0000185499,Guanylate Cyclase Activators,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000185499,,
Pharmacologic Class,N0000000146,Androgen Receptor Agonists,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000000146,,
Pharmacologic Class,N0000006496,Nicotine,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000006496,,
Pharmacologic Class,N0000175808,Hydroxyphenylpyruvate Dioxygenase Inhibitors,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000175808,,
Pharmacologic Class,N0000175728,Central Nervous System Depression,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000175728,,
Pharmacologic Class,N0000007641,Nicotinic Acids,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000007641,,
Pharmacologic Class,N0000007568,Oxazolidinones,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000007568,,
Pharmacologic Class,N0000175850,Melanin Synthesis Inhibitors,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000175850,,
Pharmacologic Class,N0000190482,Phenylalanine Hydroxylase Activators,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000190482,,
Pharmacologic Class,N0000170119,PPAR gamma,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000170119,,
Pharmacologic Class,N0000009456,Increased Norepinephrine Activity,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000009456,,
Pharmacologic Class,N0000000206,Xanthine Oxidase Inhibitors,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000000206,,
Pharmacologic Class,N0000009871,Stimulation Large Intestine Fluid/Electrolyte Secretion,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000009871,,
Pharmacologic Class,N0000009724,Inhibition Gastric Acid Secretion,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000009724,,
Pharmacologic Class,N0000000183,Acetyl Aldehyde Dehydrogenase Inhibitors,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000000183,,
Pharmacologic Class,N0000009269,Increased Cytokine Production,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000009269,,
Pharmacologic Class,N0000175073,Platinum-containing Compounds,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000175073,,
Pharmacologic Class,N0000000207,Histamine Receptor Antagonists,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000000207,,
Pharmacologic Class,N0000175817,Serotonin 3 Receptor Antagonists,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000175817,,
Pharmacologic Class,N0000175635,Factor Xa Inhibitors,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000175635,,
Pharmacologic Class,N0000007822,Polymyxins,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000007822,,
Pharmacologic Class,N0000007542,Benzodiazepines,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000007542,,
Pharmacologic Class,N0000006801,Bile Acids and Salts,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000006801,,
Pharmacologic Class,N0000009801,Photosensitizing Activity,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000009801,,
Pharmacologic Class,N0000000102,Norepinephrine Uptake Inhibitors,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000000102,,
Pharmacologic Class,N0000191280,Lipoglycopeptides,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000191280,,
Pharmacologic Class,N0000009526,Increased Prostaglandin Activity,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000009526,,
Pharmacologic Class,N0000011310,Aldosterone Antagonists,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000011310,,
Pharmacologic Class,N0000000154,Opioid Antagonists,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000000154,,
Pharmacologic Class,N0000007196,Iodine,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000007196,,
Pharmacologic Class,N0000182137,Cytochrome P450 2D6 Inhibitors,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000182137,,
Pharmacologic Class,N0000007522,Allylamine,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000007522,,
Pharmacologic Class,N0000020081,Increased Calcium-sensing Receptor Sensitivity,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000020081,,
Pharmacologic Class,N0000175755,DOPA Decarboxylase Inhibitors,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000175755,,
Pharmacologic Class,N0000191274,UGT2B15 Inhibitors,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000191274,,
Pharmacologic Class,N0000007780,Vinca Alkaloids,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000007780,,
Pharmacologic Class,N0000175450,Corticosteroid Hormone Receptor Agonists,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000175450,,
Pharmacologic Class,N0000000150,Protein Synthesis Inhibitors,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000000150,,
Pharmacologic Class,N0000175686,Competitive Opioid Antagonists,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000175686,,
Pharmacologic Class,N0000000174,Opioid Agonists,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000000174,,
Pharmacologic Class,N0000006688,Carnitine,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000006688,,
Pharmacologic Class,N0000175375,Peroxisome Proliferator-activated Receptor alpha Agonists,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000175375,,
Pharmacologic Class,N0000010217,Photoabsorption,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000010217,,
Pharmacologic Class,N0000175788,Adenosine Receptor Agonists,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000175788,,
Pharmacologic Class,N0000175644,Decreased Autonomic Ganglionic Activity,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000175644,,
Pharmacologic Class,N0000184148,Smoothened Receptor Antagonists,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000184148,,
Pharmacologic Class,N0000175763,Serotonin 1b Receptor Agonists,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000175763,,
Pharmacologic Class,N0000009905,Vascular Sclerosing Activity,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000009905,,
Pharmacologic Class,N0000175075,Proteasome Inhibitors,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000175075,,
Pharmacologic Class,N0000007698,Biguanides,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000007698,,
Pharmacologic Class,N0000009393,Increased Medullary Respiratory Drive,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000009393,,
Pharmacologic Class,N0000008016,Barbiturates,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000008016,,
Pharmacologic Class,N0000190109,Organic Anion Transporting Polypeptide 2B1 Inhibitors,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000190109,,
Pharmacologic Class,N0000000104,Cholinergic Muscarinic Agonists,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000000104,,
Pharmacologic Class,N0000008065,Purines,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000008065,,
Pharmacologic Class,N0000180999,Angiotensin 2 Type 1 Receptor Antagonists,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000180999,,
Pharmacologic Class,N0000175086,Phosphodiesterase 3 Inhibitors,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000175086,,
Pharmacologic Class,N0000175970,Increased Platelet Production,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000175970,,
Pharmacologic Class,N0000191278,UGT1A9 Inhibitors,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000191278,,
Pharmacologic Class,N0000009917,Adrenergic alpha1-Agonists,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000009917,,
Pharmacologic Class,N0000020026,Phosphodiesterase 5 Inhibitors,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000020026,,
Pharmacologic Class,N0000175632,Decreased Fibrinolysis,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000175632,,
Pharmacologic Class,N0000184145,Chloride Channel Activation Potentiators,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000184145,,
Pharmacologic Class,N0000190118,Cytochrome P450 3A Inducers,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000190118,,
Pharmacologic Class,N0000020074,Phosphate Chelating Activity,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000020074,,
Pharmacologic Class,N0000008217,Azoles,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000008217,,
Pharmacologic Class,N0000175547,Reduction Activity,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000175547,,
Pharmacologic Class,N0000175917,Thyroid Hormone Synthesis Inhibitors,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000175917,,
Pharmacologic Class,N0000167510,"Estrogens, Conjugated (USP)",FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000167510,,
Pharmacologic Class,N0000166743,Esters,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000166743,,
Pharmacologic Class,N0000182960,Phosphodiesterase 4 Inhibitors,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000182960,,
Pharmacologic Class,N0000175969,Increased Megakaryocyte Maturation,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000175969,,
Pharmacologic Class,N0000175076,Protein Kinase Inhibitors,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000175076,,
Pharmacologic Class,N0000186778,Microsomal Triglyceride Transfer Protein Inhibitors,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000186778,,
Pharmacologic Class,N0000000166,alpha Glucosidase Inhibitors,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000000166,,
Pharmacologic Class,N0000007961,"Heparin, Low-Molecular-Weight",FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000007961,,
Pharmacologic Class,N0000175513,Dipeptidase Inhibitors,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000175513,,
Pharmacologic Class,N0000000191,Dihydrofolate Reductase Inhibitors,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000000191,,
Pharmacologic Class,N0000185504,Cytochrome P450 2C9 Inhibitors,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000185504,,
Pharmacologic Class,N0000007570,Pyridines,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000007570,,
Pharmacologic Class,N0000175862,Magnetic Resonance Contrast Activity,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000175862,,
Pharmacologic Class,N0000191258,RNA Replicase Inhibitors,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000191258,,
Pharmacologic Class,N0000175459,Nucleoside Analog,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000175459,,
Pharmacologic Class,N0000178324,Increased Hematopoietic Stem Cell Mobilization,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000178324,,
Pharmacologic Class,N0000011418,Streptogramins,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000011418,,
Pharmacologic Class,N0000182140,Cytochrome P450 2C19 Inhibitors,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000182140,,
Pharmacologic Class,N0000175370,Cholinergic Antagonists,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000175370,,
Pharmacologic Class,N0000008553,Decreased Cholesterol Absorption,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000008553,,
Pharmacologic Class,N0000007620,Ergot Alkaloids,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000007620,,
Pharmacologic Class,N0000007948,Tetracyclines,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000007948,,
Pharmacologic Class,N0000000190,Histamine H1 Receptor Antagonists,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000000190,,
Pharmacologic Class,N0000008330,Cardiac Rhythm Alteration,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000008330,,
Pharmacologic Class,N0000008054,Sulfonylurea Compounds,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000008054,,
Pharmacologic Class,N0000007770,Deoxyuridine,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000007770,,
Pharmacologic Class,N0000000122,Adrenergic Agonists,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000000122,,
Pharmacologic Class,N0000000202,beta Lactamase Inhibitors,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000000202,,
Pharmacologic Class,N0000007707,Diphosphonates,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000007707,,
Pharmacologic Class,N0000191423,Multidrug and Toxin Extrusion Transporter 1 Inhibitors,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000191423,,
Pharmacologic Class,N0000175965,Increased Prothrombin Activity,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000175965,,
Pharmacologic Class,N0000009022,Digestive/GI System Activity Alteration,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000009022,,
Pharmacologic Class,N0000007530,Anthracyclines,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000007530,,
Pharmacologic Class,N0000006165,Triiodothyronine,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000006165,,
Pharmacologic Class,N0000008853,Decreased RNA Replication,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000008853,,
Pharmacologic Class,N0000175975,General Anesthesia,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000175975,,
Pharmacologic Class,N0000006014,Pyrethrins,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000006014,,
Pharmacologic Class,N0000000069,Calcium Channel Antagonists,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000000069,,
Pharmacologic Class,N0000008732,Decreased Mitosis,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000008732,,
Pharmacologic Class,N0000000168,Selective Estrogen Receptor Modulators,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000000168,,
Pharmacologic Class,N0000009267,Increased Cytokine Activity,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000009267,,
Pharmacologic Class,N0000006320,Vasopressins,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000006320,,
Pharmacologic Class,N0000011311,Monobactams,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000011311,,
Pharmacologic Class,N0000187061,Organic Cation Transporter 2 Inhibitors,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000187061,,
Pharmacologic Class,N0000000209,Adrenergic alpha-Agonists,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000000209,,
Pharmacologic Class,N0000007621,Ergotamines,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000007621,,
Pharmacologic Class,N0000175508,Lipopeptides,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000175508,,
Pharmacologic Class,N0000175702,Partial Cholinergic Nicotinic Agonists,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000175702,,
Pharmacologic Class,N0000007681,Amides,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000007681,,
Pharmacologic Class,N0000182728,Potassium Channel Openers,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000182728,,
Pharmacologic Class,N0000000236,Alkylating Activity,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000000236,,
Pharmacologic Class,N0000182638,HCV NS3/4A Protease Inhibitors,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000182638,,
Pharmacologic Class,N0000007566,Benzylamines,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000007566,,
Pharmacologic Class,N0000178478,Increased Blood Pressure,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000178478,,
Pharmacologic Class,N0000009923,Adrenergic beta1-Antagonists,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000009923,,
Pharmacologic Class,N0000170118,PPAR alpha,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000170118,,
Pharmacologic Class,N0000007893,Glycosaminoglycans,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000007893,,
Pharmacologic Class,N0000175445,Chemokine Co-receptor 5 Antagonists,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000175445,,
Pharmacologic Class,N0000175721,Nonsteroidal Anti-inflammatory Compounds,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000175721,,
Pharmacologic Class,N0000009945,Antidiuretic Hormone Antagonists,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000009945,,
Pharmacologic Class,N0000007606,Quinolones,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000007606,,
Pharmacologic Class,N0000011402,Estradiol Congeners,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000011402,,
Pharmacologic Class,N0000166469,Thiazides,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000166469,,
Pharmacologic Class,N0000009048,GI Motility Alteration,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000009048,,
Pharmacologic Class,N0000006290,Vitamin K,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000006290,,
Pharmacologic Class,N0000008157,Cardiac Glycosides,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000008157,,
Pharmacologic Class,N0000191275,UGT1A3 Inhibitors,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000191275,,
Pharmacologic Class,N0000175550,Decreased Immunologic Activity,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000175550,,
Pharmacologic Class,N0000007663,Nitroimidazoles,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000007663,,
Pharmacologic Class,N0000011161,Cephalosporins,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000011161,,
Pharmacologic Class,N0000175685,Partial Opioid Agonists,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000175685,,
Pharmacologic Class,N0000175372,Appetite Suppression,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000175372,,
Pharmacologic Class,N0000007889,Glycopeptides,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000007889,,
Pharmacologic Class,N0000009982,Decreased Sebaceous Gland Activity,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000009982,,
Pharmacologic Class,N0000008556,Decreased Coagulation Factor Activity,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000008556,,
Pharmacologic Class,N0000175085,Microtubule Inhibition,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000175085,,
Pharmacologic Class,N0000000194,Somatostatin Receptor Agonists,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000000194,,
Pharmacologic Class,N0000190855,Vesicular Monoamine Transporter 2 Inhibitors,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000190855,,
Pharmacologic Class,N0000009065,Hematologic Activity Alteration,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000009065,,
Pharmacologic Class,N0000184143,Carbamoyl Phosphate Synthetase 1 Activators,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000184143,,
Pharmacologic Class,N0000175733,Neuromuscular Depolarizing Blockade,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000175733,,
Pharmacologic Class,N0000175436,Neuraminidase Inhibitors,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000175436,,
Pharmacologic Class,N0000191266,Cytochrome P450 1A2 Inducers,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000191266,,
Pharmacologic Class,N0000007246,Estradiol,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000007246,,
Pharmacologic Class,N0000007706,Prostaglandins,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000007706,,
Pharmacologic Class,N0000000196,GABA A Agonists,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000000196,,
Pharmacologic Class,N0000175542,M2 Protein Inhibitors,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000175542,,
Pharmacologic Class,N0000175624,mTOR Inhibitors,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000175624,,
Pharmacologic Class,N0000175955,5-Lipoxygenase Inhibitors,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000175955,,
Pharmacologic Class,N0000182141,Cytochrome P450 3A4 Inhibitors,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000182141,,
Pharmacologic Class,N0000190115,Cytochrome P450 3A5 Inhibitors,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000190115,,
Pharmacologic Class,N0000175361,Catecholamine Synthesis Inhibitors,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000175361,,
Pharmacologic Class,N0000175460,Non-Nucleoside Analog,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000175460,,
Pharmacologic Class,N0000010258,X-Ray Contrast Activity,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000010258,,
Pharmacologic Class,N0000007672,Polyenes,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000007672,,
Pharmacologic Class,N0000020000,Receptor Tyrosine Kinase Inhibitors,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000020000,,
Pharmacologic Class,N0000175735,Decreased Striated Muscle Tone,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000175735,,
Pharmacologic Class,N0000007556,Dihydropyridines,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000007556,,
Pharmacologic Class,N0000009034,Emesis Suppression,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000009034,,
Pharmacologic Class,N0000008663,Decreased Immunologically Active Molecule Activity,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000008663,,
Pharmacologic Class,N0000175761,Monoamine Oxidase-B Inhibitors,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000175761,,
Pharmacologic Class,N0000190110,Organic Anion Transporter 1 Inhibitors,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000190110,,
Pharmacologic Class,N0000175084,Gonadotropin Releasing Hormone Receptor Antagonists,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000175084,,
Pharmacologic Class,N0000009916,Lipase Inhibitors,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000009916,,
Pharmacologic Class,N0000007683,Organometallic Compounds,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000007683,,
Pharmacologic Class,N0000175976,Local Anesthesia,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000175976,,
Pharmacologic Class,N0000175456,Chloride Channel Activators,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000175456,,
Pharmacologic Class,N0000000111,Folic Acid Metabolism Inhibitors,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000000111,,
Pharmacologic Class,N0000009079,Increased Acetylcholine Activity,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000009079,,
Pharmacologic Class,N0000185503,P-Glycoprotein Inhibitors,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000185503,,
Pharmacologic Class,N0000175964,Vitamin K Inhibitors,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000175964,,
Pharmacologic Class,N0000175982,Reversed Anticoagulation Activity,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000175982,,
Pharmacologic Class,N0000175629,Increased Histamine Release,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000175629,,
Pharmacologic Class,N0000166489,Quaternary Ammonium Compounds,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000166489,,
Pharmacologic Class,N0000191277,UGT1A6 Inhibitors,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000191277,,
Pharmacologic Class,N0000007700,Retinoids,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000007700,,
Pharmacologic Class,N0000009010,Decreased Tracheobronchial Stretch Receptor Activity,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000009010,,
Pharmacologic Class,N0000190107,Organic Anion Transporting Polypeptide 1B1 Inhibitors,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000190107,,
Pharmacologic Class,N0000000109,Serotonin Uptake Inhibitors,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000000109,,
Pharmacologic Class,N0000020060,DNA Polymerase Inhibitors,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000020060,,
Pharmacologic Class,N0000009918,Adrenergic alpha2-Agonists,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000009918,,
Pharmacologic Class,N0000008867,Decreased Respiratory Secretion Viscosity,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000008867,,
Pharmacologic Class,N0000020019,Glucosylceramide Synthase Inhibitors,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000020019,,
Pharmacologic Class,N0000008118,Xanthines,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000008118,,
Pharmacologic Class,N0000182147,Sigma-1 Receptor Agonists,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000182147,,
Pharmacologic Class,N0000000144,Iron Chelating Activity,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000000144,,
Pharmacologic Class,N0000008841,Decreased Protein Synthesis,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000008841,,
Pharmacologic Class,N0000006806,Amino Acids,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000006806,,
Pharmacologic Class,N0000009059,Genitourinary Arterial Vasodilation,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000009059,,
Pharmacologic Class,N0000175533,Dyes,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000175533,,
Pharmacologic Class,N0000175851,Depigmenting Activity,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000175851,,
Pharmacologic Class,N0000185607,Cytochrome P450 2C19 Inducers,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000185607,,
Pharmacologic Class,N0000175628,Decreased Histamine Release,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000175628,,
Pharmacologic Class,N0000175651,Increased Sympathetic Activity,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000175651,,
Pharmacologic Class,N0000009922,Adrenergic beta2-Agonists,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000009922,,
Pharmacologic Class,N0000185507,Cytochrome P450 2C9 Inducers,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000185507,,
Pharmacologic Class,N0000175650,Decreased Sympathetic Activity,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000175650,,
Pharmacologic Class,N0000191269,UDP Glucuronosyltransferases Inhibitors,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000191269,,
Pharmacologic Class,N0000175472,Metal Chelating Activity,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000175472,,
Pharmacologic Class,N0000007911,Rifamycins,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000007911,,
Pharmacologic Class,N0000000125,Cholinergic Muscarinic Antagonists,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000000125,,
Pharmacologic Class,N0000181815,Sphingosine 1-Phosphate Receptor Modulators,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000181815,,
Pharmacologic Class,N0000007710,"Prostaglandins E, Synthetic",FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000007710,,
Pharmacologic Class,N0000191276,UGT1A4 Inhibitors,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000191276,,
Pharmacologic Class,N0000175833,Acidifying Activity,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000175833,,
Pharmacologic Class,N0000009924,Adrenergic beta2-Antagonists,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000009924,,
Pharmacologic Class,N0000000243,Androgen Receptor Antagonists,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000000243,,
Pharmacologic Class,N0000007983,Hydroxy Acids,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000007983,,
Pharmacologic Class,N0000007883,Amphetamines,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000007883,,
Pharmacologic Class,N0000175968,Thrombopoietin Receptor Agonists,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000175968,,
Pharmacologic Class,N0000175479,Amphenicols,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000175479,,
Pharmacologic Class,N0000006276,Vitamin B 12,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000006276,,
Pharmacologic Class,N0000175684,Full Opioid Agonists,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000175684,,
Pharmacologic Class,N0000191273,UGT2B7 Inhibitors,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000191273,,
Pharmacologic Class,N0000171131,Allergens,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000171131,,
Pharmacologic Class,N0000182143,P2Y12 Receptor Antagonists,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000182143,,
Pharmacologic Class,N0000186774,Diarylquinolines,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000186774,,
Pharmacologic Class,N0000007853,Aminoglycosides,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000007853,,
Pharmacologic Class,N0000008478,Decreased Cell Wall Integrity,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000008478,,
Pharmacologic Class,N0000000233,Nucleic Acid Synthesis Inhibitors,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000000233,,
Pharmacologic Class,N0000000239,P-Glycoprotein Interactions,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000000239,,
Pharmacologic Class,N0000000106,Prostaglandin Receptor Agonists,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000000106,,
Pharmacologic Class,N0000011294,Carbapenems,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000011294,,
Pharmacologic Class,N0000175442,Lincosamides,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000175442,,
Pharmacologic Class,N0000000246,HIV Protease Inhibitors,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000000246,,
Pharmacologic Class,N0000181819,Uncompetitive NMDA Receptor Antagonists,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000181819,,
Pharmacologic Class,N0000175433,pleuromutilin,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000175433,,
Pharmacologic Class,N0000175549,Cystine Disulfide Reduction,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000175549,,
Pharmacologic Class,N0000191624,Cytochrome P450 1A Inducers,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000191624,,
Pharmacologic Class,N0000005934,Progesterone,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000005934,,
Pharmacologic Class,N0000175912,Dipeptidyl Peptidase 4 Inhibitors,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000175912,,
Pharmacologic Class,N0000185506,Cytochrome P450 3A4 Inducers,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000185506,,
Pharmacologic Class,N0000175448,Potassium Channel Antagonists,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000175448,,
Pharmacologic Class,N0000187058,Sodium-Glucose Transporter 2 Inhibitors,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000187058,,
Pharmacologic Class,N0000008241,Androstanes,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000008241,,
Pharmacologic Class,N0000000176,Topoisomerase Inhibitors,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000000176,,
Pharmacologic Class,N0000007888,Bismuth,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000007888,,
Pharmacologic Class,N0000175374,Peroxisome Proliferator-activated Receptor Activity,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000175374,,
Pharmacologic Class,N0000190113,Breast Cancer Resistance Protein Inhibitors,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000190113,,
Pharmacologic Class,N0000006337,Ergocalciferols,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000006337,,
Pharmacologic Class,N0000175469,Pyrophosphate Analog,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000175469,,
Pharmacologic Class,N0000000250,Melatonin Receptor Agonists,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000000250,,
Pharmacologic Class,N0000175365,Bile-acid Binding Activity,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000175365,,
Pharmacologic Class,N0000175730,Centrally-mediated Muscle Relaxation,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000175730,,
Pharmacologic Class,N0000175366,Increased Diuresis at Loop of Henle,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000175366,,
Pharmacologic Class,N0000008010,Cannabinoids,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000008010,,
Pharmacologic Class,N0000007658,Nitrofurans,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000007658,,
Pharmacologic Class,N0000020015,NMDA Receptor Antagonists,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000020015,,
Pharmacologic Class,N0000009909,Vasodilation,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000009909,,
Pharmacologic Class,N0000182139,Cytochrome P450 2B6 Inhibitors,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000182139,,
Pharmacologic Class,N0000175962,Lead Chelating Activity,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000175962,,
Pharmacologic Class,N0000011301,Progesterone Congeners,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000011301,,
Pharmacologic Class,N0000008638,Decreased GnRH Secretion,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000008638,,
Pharmacologic Class,N0000008048,Sulfonamides,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000008048,,
Pharmacologic Class,N0000190108,Organic Anion Transporting Polypeptide 1B3 Inhibitors,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000190108,,
Pharmacologic Class,N0000000100,Estrogen Receptor Agonists,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000000100,,
Pharmacologic Class,N0000008577,Decreased DNA Replication,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000008577,,
Pharmacologic Class,N0000175972,Decreased Platelet Production,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000175972,,
Pharmacologic Class,N0000011280,Prostaglandins I,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000011280,,
